AML is on the go. Chart heading up. AML up >7% to 89c today....

AML is on the go. Chart heading up. AML up >7% to 89c today. Also check today's ASX announcement.

This is all good for CIR with 22% ownership of AML + other holdings. CIR is undervalued relative to CIR's NTA.

Optiscan Imaging (Circadian holding 8%) is involved in research and development in biomedical imaging, with core technology in live microscopic imaging for clinical examinations.

Metabolic Pharmaceuticals is an R&D company (Circadian holding 22%) developing therapies for metabolic diseases with application to large global markets.

Operating in the areas of cell-based screening, functional genomics, and neurosciences, Axon Instruments (Circadian holding 15%) develops and manufactures high-technology devices and software for drug discovery.

In collaboration with its technology and scientific partners, Antisense Therapeutics (Circadian holding 27%) is seeking to develop a pipeline of antisense drugs for a range of medical conditions, including multiple sclerosis and psoriasis.

Amrad Corporation (Circadian holding 22%) is a biotechnology research and development company with a portfolio including potential treatments for a range of diseases.

www.circadian.com.au/investment.htm